Anika Therapeutics, Inc. (ANIK)
$21.20+$0.26 (+1.25%) Today
Latest ANIK Insider Trades
Gary P. Fischetti - DirectorOpen-market purchase$21K
Gary P. Fischetti - DirectorGary P. Fischetti - DirectorGary P. Fischetti
Joseph H. CapperAnika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 2,000 | $41K |
| Grant or award | 5 | 52,010 | |
| Option exercise | 2 | 25,680 | |
| Tax withholding / forfeiture | 1 | 3,769 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
22 Form 4 filings on record, the earliest from Oct 4, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gary P. Fischetti - Director | Open-market purchase | Common Stock | 1,000 | $20.75 | $21K | |
| Gary P. Fischetti - Director | Open-market purchase | Common Stock | 1,000 | $20.32 | $20K | |
| Gary P. Fischetti | Grant or award | Common Stock | 10,402 | $0.00 | - | |
| John B. Henneman III | Grant or award | Common Stock | 10,402 | $0.00 | - | |
| Stephen Richard | Grant or award | Common Stock | 10,402 | $0.00 | - | |
| Joseph H. Capper | Grant or award | Common Stock | 10,402 | $0.00 | - | |
| Sheryl L. Conley | Grant or award | Common Stock | 10,402 | $0.00 | - | |
 Stephen D. Griffin - Officer | Option exercise | Common Stock | 12,840 | - | - | |
| Stephen D. Griffin - Officer | Tax withholding / forfeiture | Common Stock | 3,769 | $14.41 | $54K | |
| Stephen D. Griffin - Officer | Option exercise | Restricted Stock Unit | 12,840 | $0.00 | - | |
| John B. Henneman III | Open-market purchase | Common Stock | 5,000 | $14.66 | $73K | |
| Ian McLeod - Officer | Grant or award | Restricted Stock Unit | 13,097 | $0.00 | - | |
| Ian McLeod - Officer | Grant or award | Restricted Stock Unit | 11,194 | $0.00 | - | |
| Ian McLeod - Officer | Grant or award | Premium Priced Stock Appreciation Rights | 17,663 | $0.00 | - | |
| David Colleran - Officer | Option exercise | Common Stock | 9,388 | - | - | |
| David Colleran - Officer | Grant or award | Common Stock | 4,694 | $0.00 | - | |
| David Colleran - Officer | Tax withholding / forfeiture | Common Stock | 4,168 | $14.20 | $59K | |
| David Colleran - Officer | Option exercise | Common Stock | 6,449 | - | - | |
| David Colleran - Officer | Tax withholding / forfeiture | Common Stock | 1,893 | $14.20 | $27K | |
| David Colleran - Officer | Option exercise | Restricted Stock Unit | 9,388 | $0.00 | - | |
| David Colleran - Officer | Option exercise | Restricted Stock Unit | 6,449 | $0.00 | - | |
| Stephen D. Griffin - Officer | Option exercise | Common Stock | 12,824 | - | - | |
| Stephen D. Griffin - Officer | Grant or award | Common Stock | 6,412 | $0.00 | - | |
| Stephen D. Griffin - Officer | Tax withholding / forfeiture | Common Stock | 5,944 | $14.20 | $84K | |
| Stephen D. Griffin - Officer | Option exercise | Restricted Stock Unit | 12,824 | $0.00 | - | |
| Cheryl R. Blanchard | Option exercise | Common Stock | 24,519 | - | - | |
| Cheryl R. Blanchard | Grant or award | Common Stock | 24,520 | $0.00 | - | |
| Cheryl R. Blanchard | Tax withholding / forfeiture | Common Stock | 14,728 | $14.20 | $209K | |
| Cheryl R. Blanchard | Option exercise | Common Stock | 25,131 | - | - | |
| Cheryl R. Blanchard | Tax withholding / forfeiture | Common Stock | 12,104 | $14.20 | $172K | |
| Cheryl R. Blanchard | Option exercise | Restricted Stock Unit | 24,519 | $0.00 | - | |
| Cheryl R. Blanchard | Option exercise | Restricted Stock Unit | 25,131 | $0.00 | - | |
| Ian McLeod - Officer | Option exercise | Common Stock | 3,774 | - | - | |
| Ian McLeod - Officer | Grant or award | Common Stock | 1,161 | $0.00 | - | |
| Ian McLeod - Officer | Tax withholding / forfeiture | Common Stock | 1,449 | $14.20 | $21K | |
| Ian McLeod - Officer | Option exercise | Common Stock | 2,658 | - | - | |
| Ian McLeod - Officer | Tax withholding / forfeiture | Common Stock | 781 | $14.20 | $11K | |
| Ian McLeod - Officer | Option exercise | Restricted Stock Unit | 3,774 | $0.00 | - | |
| Ian McLeod - Officer | Option exercise | Restricted Stock Unit | 2,658 | $0.00 | - | |
| David Colleran - Officer | Option exercise | Restricted Stock Unit | 5,465 | $0.00 | - | |
| David Colleran - Officer | Option exercise | Common Stock | 5,465 | - | - | |
| David Colleran - Officer | Tax withholding / forfeiture | Common Stock | 1,919 | $14.96 | $29K | |
| Cheryl R. Blanchard | Option exercise | Common Stock | 20,001 | - | - | |
| Cheryl R. Blanchard | Tax withholding / forfeiture | Common Stock | 5,871 | $14.96 | $88K | |
| Cheryl R. Blanchard | Option exercise | Restricted Stock Unit | 20,001 | $0.00 | - | |
| Ian McLeod - Officer | Option exercise | Common Stock | 2,197 | - | - | |
| Ian McLeod - Officer | Tax withholding / forfeiture | Common Stock | 639 | $14.96 | $10K | |
| Ian McLeod - Officer | Option exercise | Restricted Stock Unit | 2,197 | $0.00 | - | |
| Stephen D. Griffin - Officer | Grant or award | Stock Appreciation Rights | 310,207 | $0.00 | - | |
| Stephen D. Griffin - Officer | Grant or award | Restricted Stock Unit | 130,402 | $0.00 | - | |
| Sheryl L. Conley - Director | Grant or award | Common Stock | 14,164 | $0.00 | - | |
| John B. Henneman III - Director | Grant or award | Common Stock | 14,164 | $0.00 | - | |
| William R. Jellison - Director | Grant or award | Common Stock | 14,164 | $0.00 | - | |
| Susan L. N. Vogt - Director | Grant or award | Common Stock | 14,164 | $0.00 | - | |
| Anne Nunes - Officer | Option exercise | Common Stock | 2,491 | $0.00 | - | |
| Anne Nunes - Officer | Tax withholding / forfeiture | Common Stock | 732 | $24.27 | $18K | |
| Anne Nunes - Officer | Option exercise | Restricted Stock Unit | 2,491 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Jellison William R | Former Director | 16,864 | $355K | View on EDGAR |
Anika Therapeutics, Inc. (ANIK) had 7 insider filings in the last 90 days, with the most recent on 2026-08-05. The full record for ANIK runs to 22 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
2 insider purchases of ANIK were filed in the last 90 days, totaling $41K.
No insider sales of ANIK were filed in the last 90 days.
This page tracks ANIK Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ANIK to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
